![]() Clinical TrialsUSON 06185Breast CancerRandomized Phase II Trial of Letrozole with or without Dasatinib as First-Line Treatment for Hormone Receptor-Positive, HER2-Negative Post-Menopausal Breast Cancer that is Unresectable, Locally Recurrent or Metastatic Click here to apply for this clinical trial.Click here to view all clinical trials for this cancer type. |
The Novalis Tx is HereNow even those with previously untreatable tumors have new hope for healing.Click here for more. Seven Levels of HealingA ground-breaking education and support program now offered at multiple RMCC locations.Click here for more. ![]() CONTACT US888-259-RMCC (7622) |


